ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Research Group(s)

  • Gastrointestinal and Other Cancers

Sponsor

Massachusetts General Hospital

Status

Active, not recruiting

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT02394769

This research study is investigating the use of aspirin as a potential chemopreventive agent
to reduce risk of colorectal cancer

Intervention

Aspirin, Placebo for Aspirin

Condition

Colorectal Cancer

Investigators

Andrew T Chan, MD, MPH

See list of participating sites